CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
DAILY EQUITY REPORT 4TH SEPTEMBER 2014
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report
INDIAN FACE
INDIAN MARKET INDICES
CLOSE
PREVIOUS
SENSEX
27139.94
27019.39
NIFTY
8114.60
8083.05
INDIAN EQUITY BENCHMARK record high as software
exporters such as Infosys rallied after strong US
ASIAN MARKET
manufacturing and construction data, while continued
INDICES
CLOSE
PREVIOUS
NIKKEI
15728.35
15668.60
HANG SENG
25317.95
24749.02
KOSPI
2051.20
2051.58
foreign buying and falling oil prices also helped.
Further, Bharti Airtel was up 3% after the company said its arm signed an agreement to acquire over 2.7 million subscribers of yuMobile.
SECTORIAL INDICES INDICES
CLOSE
CHANGE (%)
CNX 100
8058.75
0.44
S&P CNX 500
6517.70
0.51
CNX MIDCAP
11509.55
0.98
CNX 200
4133.55
0.50
BANK NIFTY
16110.00
-0.31
upgrades. Morgan Stanley upgrades the stock to Overweight from Equal-weight.
GLOBAL FACE
TOP GAINERS SCRIPT
CLOSE
CHANGE (%)
COAL INDIA
377.80
3.96
INFY
3730.00
3.22
BHARTI AIRTEL
404.00
3.17
WIPRO
576.45
2.75
Shares of Tata Motors gained nearly 3%, after a slew of rating
Asian stock markets were higher, as growing expectations that the European Central Bank could announced additional easing measures continued to support.
European stocks market mixed to lower as sinking oil prices brought down energy-sector shares, though upbeat U.S. data managed to cushion losses
TOP LOSERS
U.S. stocks market dismissed escalating tensions in Ukraine
SCRIPT
CLOSE
CHANGE (%)
GAIL
454.50
-2.25
and rose on the coattails of a better-than-expected consumer
ONGC
436.90
-1.72
sentiment report.
IDFC
144.60
-1.57
BHEL
236.70
-1.50
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report MARKET MOVERS UPSIDE
TCS
2602.20
CHANGE (%) 2.53
RELIANCE
1032.50
0.85
SCRIPT
COAL INDIA INFY
CLOSE
378.00 3738.60
4.02 3.45
NIFTY SPOT S3 8016
TREND
STRATEGY
BULLISH
BUY ON DIPS
S2 8066
PIVOT POINTS P R1
S1
8090
8116
8140
SUPPORT S1-8090 S2-8040
NIFTY
R2
R3
8165
8215
RESISTANCE R1-8140 R2-8165
MARKET MOVERS DOWNSIDE SCRIPT
CLOSE
ONGC
436.05
CHANGE (%) [1.91]
ITC
348.55
[1.73]
HDFC BANK
855.95
[0.38]
SBI
2501.90
[0.8]
FII & DII ACTIVITY INSTITUTION
NET BUY (CR.)
NET SELL (CR)
FII
5200.31
5007.75
DII
1820.36
1988.21
BANK NIFTY FUTURE TREND BULLISH PIVOT POINTS S3 15817
NSE TOTALS INDICES
ADVANCES
DECLINES
NIFTY
23
27
BANK NIFTY
6
6
STRATEGY BUY ON DIPS
S2
S1
P
R1
16007
16099
16197
16289
BANK NIFTY
SUPPORT S1-16100 S2-15920
R2
R3
16387 16577 RESISTANCE R1-16295 R2-16385
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report r
MARKET TALKS maker received product patents from South Korea, China and
Eros Intl announces Partnership with Home Cable Network
Canada.
Eros International Media announced the launch of a partnership between Home Cable Network and online entertainment service
Tata Comm announces second challenge in the F1® Connectivity Innovation Prize
provider Eros Now. This subscription-based broadband streaming service will enable Home Cable Network’s customers to view their
Tata Communications confirmed the details of the second
favorite content from Eros’ library of films and music on multiple
technology challenge intended to harness global brainpower in the
devices like smart-TVs, PCs, laptops, tablets and mobiles.
USD $50,000 initiative set against the white heat of connectivity innovation that defines Formula 1® racing.
Tata Power's arm redeems US$ 450 mn Tata Power has stated that With reference to the earlier letter dated August 01, 2014, Bhira Investments Limited, a wholly owned
Tata Motors stock receiving order
up
2%
on
subsidiary of the Company, has redeemed US$ 450 Mn. Fixed to Floating Rate Subordinated Notes on September 02, 2014, as per
Shares of Tata Motors was up 2% after company received an order
the notice for early redemption to the Trustee dated July 31, 2014.
from KSRTC (Karnataka State Road Transport Corporation) to supply 487 nos. and another for 780 nos. from HRTC (Himachal
Suven Life at new high, up 5%, gets patents in 3 countries
Road Transport Corporation) for Tata Marcopolo built buses as per Urban Bus Specifications under JNNURM II scheme.
Investors lapped up shares of Suven Life Sciences after the drug
DISCLAIMER The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Use of this report in no way constitutes a client/advisor relationship, all information we communicate to you (the subscriber) either through our Web site or other forms of communications, are purely for informational purposes only. We recommend seeking individual investment advice before making any investment, for you are assuming sole liability for your investments. Capital Stars will in no way have discretionary authority over your trading or investment accounts. All rights reserved.